BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1729360)

  • 21. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity.
    Zangemeister-Wittke U; Kyewski B; Schirrmacher V
    J Immunol; 1989 Jul; 143(1):379-85. PubMed ID: 2499633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulatory role of Ig isotypes. I. Induction of contrasuppressor T cells for contact sensitivity responses by antibodies of the IgM, IgG1, and IgG3 isotypes.
    Ptak W; Flood PM; Janeway CA; Marcinkiewicz J; Green DR
    J Immunol; 1988 Aug; 141(3):756-64. PubMed ID: 2456332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions.
    Li L; Sad S; Kägi D; Mosmann TR
    J Immunol; 1997 May; 158(9):4152-61. PubMed ID: 9126975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
    Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
    J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cascade of T-T interactions, mediated by the linked recognition of antigen, in the induction of T cells able to help delayed-type hypersensitivity responses.
    Bretscher PA
    J Immunol; 1986 Dec; 137(12):3726-33. PubMed ID: 2431041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).
    Murphy JW; Mosley RL
    J Immunol; 1985 Jan; 134(1):577-84. PubMed ID: 3155471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type II collagen-induced murine arthritis. II. Genetic control of arthritis induction is expressed on L3T4+ T cells required for humoral as well as cell-mediated immune responses to type II collagen.
    Seki N; Sudo Y; Yamane A; Sugihara S; Takai Y; Ishihara K; Ono S; Hamaoka T; Senoh H; Fujiwara H
    Reg Immunol; 1989; 2(4):203-12. PubMed ID: 2577123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.
    Murphy JW; Moorhead JW
    J Immunol; 1982 Jan; 128(1):276-83. PubMed ID: 6172483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
    Walker PR; Fellowes R; Hecht EM; Lehner T
    J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production.
    Fidel PL; Boros DL
    J Immunol; 1990 Aug; 145(4):1257-64. PubMed ID: 2143210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD; Schreiber H; Bluestone JA
    J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.